ALECR fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Eurofins-Cerep SA engages in the provision of preclinical drug research services. The firm’s BioPrint, allows the modeling of clinical effects of drug candidates from molecular properties. Its services include compound management, high-throughput screening, in vitro safety profiling, assay development, and profile design. The company was founded on December 20, 1989 and is headquartered in Celle l'Evescault, France.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
ALECR has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company